ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets
Abstract Background This study aims to investigate the involvement of acid sphingomyelinase (ASM) in the pathology of dermatomyositis (DM), making it a potential therapeutic target for DM. Methods Patients with DM and healthy controls (HCs) were included to assess the serum level and activity of ASM...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMC
2024-07-01
|
| Colección: | Skeletal Muscle |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s13395-024-00347-1 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|